Canada markets closed

Elite Pharmaceuticals, Inc. (ELTP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1298+0.0006 (+0.49%)
At close: 02:35PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 132.12M
Enterprise Value 134.19M
Trailing P/E 6.91
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.79
Price/Book (mrq)2.85
Enterprise Value/Revenue 2.84
Enterprise Value/EBITDA -413.45

Trading Information

Stock Price History

Beta (5Y Monthly) -0.14
52-Week Change 3333.33%
S&P500 52-Week Change 322.38%
52 Week High 30.2100
52 Week Low 30.0300
50-Day Moving Average 30.1438
200-Day Moving Average 30.1249

Share Statistics

Avg Vol (3 month) 3944.01k
Avg Vol (10 day) 3511.79k
Shares Outstanding 51.02B
Implied Shares Outstanding 61.02B
Float 8797.53M
% Held by Insiders 122.23%
% Held by Institutions 10.00%
Shares Short (Apr 30, 2009) 4757.07k
Short Ratio (Apr 30, 2009) 40.87
Short % of Float (Apr 30, 2009) 4N/A
Short % of Shares Outstanding (Apr 30, 2009) 42.16%
Shares Short (prior month Mar 31, 2009) 41.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 32.87%
Operating Margin (ttm)22.73%

Management Effectiveness

Return on Assets (ttm)6.83%
Return on Equity (ttm)40.62%

Income Statement

Revenue (ttm)47.32M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)68.00%
Gross Profit (ttm)N/A
EBITDA 8.3M
Net Income Avi to Common (ttm)15.55M
Diluted EPS (ttm)0.0200
Quarterly Earnings Growth (yoy)-76.20%

Balance Sheet

Total Cash (mrq)5.82M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)7.89M
Total Debt/Equity (mrq)16.99%
Current Ratio (mrq)1.94
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-2.37M
Levered Free Cash Flow (ttm)-2.5M